How to Source Gliclazide + Metformin Tablets(ER) for Pharmaceutical Formulation
Gliclazide + Metformin Tablets(ER) (Tablets(ER), Gliclazide 30 mg/60 mg + Metformin 500/1000 mg) is classified under Diabetes. It is therapeutically aligned with reference brands such as Glizid-M XR(US & EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Gliclazide + Metformin Tablets(ER) for formulation, R&D, or bulk manufacturing.
Product Overview:
Gliclazide, a sulfonylurea, stimulates insulin secretion from pancreatic β-cells, while Metformin decreases hepatic glucose production and improves insulin sensitivity. This extended-release combination ensures stable blood glucose levels, reduces postprandial spikes, and improves patient adherence through once-daily dosing—offering synergistic control for type 2 diabetes with a lower risk of hypoglycemia.
Gliclazide + Metformin Tablets(ER) API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Gliclazide + Metformin Tablets(ER) must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Gliclazide + Metformin Tablets(ER) is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Gliclazide + Metformin Tablets(ER) is more than procurement—it’s a strategic partnership. With its tablets(er) form and Gliclazide 30 mg/60 mg + Metformin 500/1000 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Gliclazide + Metformin Tablets(ER).
Request a Quote
Frequently Asked Questions For Sourcing of Gliclazide + Metformin Tablets(ER)
What is the typical lead time for Gliclazide + Metformin Tablets(ER)?
Lead times range from 4–6 weeks depending on supplier and region.
Is Gliclazide + Metformin Tablets(ER) available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Gliclazide + Metformin Tablets(ER) require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Gliclazide + Metformin Tablets(ER)?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Gliclazide + Metformin Tablets(ER)?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Gliclazide + Metformin Tablets(ER)?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Gliclazide + Metformin Tablets(ER) suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Gliclazide + Metformin Tablets(ER) be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.